StockData
QuidelOrtho Corp logo

QuidelOrtho Corp (QDEL) stock

QDELNasdaqIn Vitro & In Vivo Diagnostic SubstancesFiscal year ends January 1
Financials through Q3 FY2026, quarter ended Sep 27, 2026Last filing: 10-Q on Nov 4, 2026Score 6/3063% below fair value
$9.87−0.34 (-3.33%)

Close on Nov 17, 2026Market cap $676.84MP/E –Yield –

QuidelOrtho total debt

Total debt is short-term plus long-term borrowings on the balance sheet at the end of each period.

QuidelOrtho's total debt was $2.94B at Sep 27, 2026. For fiscal 2025 it was $2.65B, up 6.7% from the year before. The highest annual figure on record is $2.65B in fiscal 2025.

Annual total debt

PeriodPeriod endValueChange
FY2025Dec 28, 2025$2.65B+6.7%
FY2024Dec 29, 2024$2.48B+2.8%
FY2023Dec 31, 2023$2.41B-8.5%
FY2022Jan 1, 2023$2.64B+263730.0%
FY2021Jan 2, 2022$1.00M–

Quarterly total debt

Change is against the same quarter a year earlier.

PeriodPeriod endValueChange
Q3 FY2026Sep 27, 2026$2.94B+10.5%
Q2 FY2026Jun 28, 2026$2.89B+10.9%
Q1 FY2026Mar 29, 2026$2.69B+7.5%
Q4 FY2025Dec 28, 2025$2.65B+6.7%
Q3 FY2025Sep 28, 2025$2.66B+4.3%
Q2 FY2025Jun 29, 2025$2.61B+1.7%
Q1 FY2025Mar 30, 2025$2.50B+4.1%
Q4 FY2024Dec 29, 2024$2.48B+2.8%
Q3 FY2024Sep 29, 2024$2.55B-4.1%
Q2 FY2024Jun 30, 2024$2.56B-5.9%
Q1 FY2024Mar 31, 2024$2.40B-14.0%
Q4 FY2023Dec 31, 2023$2.41B-8.5%
Q3 FY2023Oct 1, 2023$2.66B-8.2%
Q2 FY2023Jul 2, 2023$2.72B-7.7%
Q1 FY2023Apr 2, 2023$2.79B+279360.0%
Q4 FY2022Jan 1, 2023$2.64B–
Q3 FY2022Oct 2, 2022$2.90B–
Q2 FY2022Jul 3, 2022$2.95B–
Q4 FY2021Jan 2, 2022$1.00M–

More QuidelOrtho figures

See a number that looks wrong?